Observational Study
Copyright ©The Author(s) 2015.
World J Gastroenterol. May 28, 2015; 21(20): 6287-6295
Published online May 28, 2015. doi: 10.3748/wjg.v21.i20.6287
Table 2 Baseline characteristics of the subjects according to gallstone disease status
Control (n = 16543)Gallstone disease (n = 1069)Gallstone disease (n = 1069)
Gallstones (n = 713)Cholecystectomy (n = 356)
Age (yr)48.1 ± 11.154.5 ± 11.4a53.8 ± 11.2b55.8 ± 11.5c
Male8122 (49.1)560 (52.4)a377 (52.9)b183 (51.4)
Waist circumference (cm)82.8 ± 8.286.4 ± 8.5a86.3 ± 8.2b86.3 ± 7.7c
Body mass index (kg/m2)23.0 ± 3.124.1 ± 3.2a24.0 ± 3.1b23.9 ± 2.9c
Systolic blood pressure (mmHg)113.5 ± 14.4116.3 ± 15.2a117.0 ± 15.0b118.4 ± 14.5c
Diastolic blood pressure (mmHg)73.3 ± 11.375.2 ± 11.4a75.2 ± 11.2b75.2 ± 10.6c
Hypertension2710 (16.4)311 (29.1)a205 (28.8)b106 (29.8)c
Diabetes771 (4.7)100 (9.4)a67 (9.4)b33 (9.3)c
Gamma-glutamyl transpeptidase (IU/L)29.8 ± 32.934.6 ± 48.8a35.7 ± 58.8b38.0 ± 75.0c
Alanine aminotransferase (IU/L)23.1 ± 19.825.9 ± 18.6a26.0 ± 17.9b26.1 ± 16.4c
Aspartate aminotransferase (IU/L)22.1 ± 12.223.2 ± 11.1a23.6 ± 10.7b24.5 ± 9.9c
Total cholesterol (mg/dL)194.4 ± 33.7193.4 ± 33.7192.5 ± 33.6190.6 ± 33.4c
Triglycerides (mg/dL)103.2 ± 68.0111.1 ± 62.3a112.9 ± 65.9b116.4 ± 72.5c
HDL-cholesterol (mg/dL)55.1 ± 12.253.2 ± 12.1a53.3 ± 12.2b53.7 ± 12.6c
Fasting glucose (mg/dL)95.2 ± 15.599.6 ± 20.4a99.6 ± 20.8b99.5 ± 17.0c
HbA1c (%)5.8 ± 0.55.9 ± 0.7a5.9 ± 0.6b6.0 ± 0.5c
Fasting insulin, μIU/mL (n = 8622)6.9 ± 4.48.3 ± 6.2a8.3 ± 6.0b8.3 ± 5.7c
HOMA- IR index (n = 8622)1.7 ± 1.32.1 ± 1.7a2.1 ± 1.7b2.2 ± 1.7c
NAFLD4896 (29.6)441 (41.3)a292 (41.0)b149 (41.9)c
Smoking
Never-smoker10042 (60.7)623 (58.3)a419 (58.8)204 (57.3)c
Current smoker2398 (14.5)135 (12.6)a95 (13.3)40 (11.2)c
Ex-smoker4103 (24.8)311 (29.1)a199 (27.9)112 (31.5)c
Regular physical activity10835 (65.5)773 (72.3)a521 (73.1)b252 (70.8)c